je.st
news
Pfizer May Cause Researchers Short-Term Pain, Long-Term Gain
2015-11-27 21:21:48| Biotech - Topix.net
The marriage of two of the biggest U.S. drugmakers is not without consequences for the rest of the health-care supply chain, particularly for the firms that handle their outsourced research and development work. Pfizer Inc. and Allergan Plc agreed Monday to a $160 billion deal that gives Pfizer a suite of new therapeutic development areas like eye care, women's health and antibiotics.
Tags: gain
pain
researchers
pfizer
Category:Biotechnology and Pharmaceuticals